2008 NSTI Nanotechnology Conference and Trade Show - Nanotech 2008 - 11th Annual
Technical Conferences
Merck Corporate Needs
NanoInk Symposium
Nano Electronics & Photonics
Nano Fabrication
MEMS & NEMS
Sensors & Systems
Micro & Nano Fluidics
MSM - Modeling Microsystems
WCM - Compact Modeling
Nanostructured Materials & Devices
Soft Nanotechnologies & Applications
Nanoparticles in Soft Materials - Colloidal Systems
Polymer Nanotechnology
Carbon Nano Structures & Devices
Nano Particles & Applications
Composites
Nanostructured Surfaces and Interfaces
Nanoscale Characterization
Energy Technologies & Applications
Nanotech in Health, Environment & Society
ICCN - Nanoscale Modeling
Nanoreliability
Bio Nano Materials & Tissues
Bio Sensors & Diagnostics
Biomarkers & Nanoparticles
Cancer Diagnostics, Imaging & Treatment
Drug Delivery & Therapeutics
Nano Medicine
Nanotech to Neurology
Phage Nanobiotechnology
Clean Technology 2008
Industrial Impact Workshop
Confirmed Speakers
Program Committee
Reviewers

Partnering Events:

TechConnect Summit
Clean Technology 2008

Drug Delivery & Therapeutics

Drug Delivery & Therapeutics

Symposium Sessions

 

Monday June 2

1:30 Nanoparticles: Nanoparticles for Biology and Medicine
1:30 Cancer Diagnosis, Imaging and Treatment - 1
 Biomarkers & Nanoparticles
 

Tuesday June 3

8:30 Cancer Diagnosis, Imaging and Treatment - 2
 Drug Delivery & Theraputics
 Merck Innovation Symposium: siRNA Delivery
 Phage Nanobiotechnology
3:30 Merck Innovation Symposium: siRNA Delivery
 

Wednesday June 4

8:30 Nanotechnology for Cancer Prevention, Diagnosis and Treatment
10:30 Nanotechnology for Cancer Prevention, Diagnosis and Treatment
10:30 Phage Nanobiotechnology
1:30 Nanotechnology for Cancer Prevention, Diagnosis and Treatment
1:30 Phage Nanobiotechnology
3:30 Nanotechnology for Cancer Prevention, Diagnosis and Treatment
4:00 Phage Nanobiotechnology
 Cancer Diagnostics, Imaging & Treatment
 

Thursday June 5

8:30 Biomarkers and Nanoparticles
10:30 Drug and Gene Delivery Systems
 

Symposium Program

 

Monday June 2

Back to Top
1:30 Nanoparticles: Nanoparticles for Biology and MedicineRoom 203
 Session chair: Srinivas Iyer, LANL, US
1:30 Effect of Medical Device Substrate Material on Nanoparticulate Silver Efficacy
B.J. Dair, K.M. Kennedy, R.S. Casas, FDA, US
1:50 The Use of Gold-Citrate Nanoparticles and Curcumin Nanomedicine to Target Cancer at a Single Cell Level
A. Moten, Harvard University, US
2:10 Combinatorial optimization, a paradigm shift in targeted particle drug delivery development
J. Wright, BIND, US
2:30 Nanomaterial: A realistic business case for Pharma
T.H. Keller, GlaxoSmithKline, UK
2:50 Towards nanosized particles in pharmaceutical industry
N.R. Bieri, U. Meier, E. Goncalves, D. Zimmermann, M. Juhnke, R. Thakur, Novartis Pharma AG, CH
Back to Top
1:30 Cancer Diagnosis, Imaging and Treatment - 1Room 208
 Session chair: Linda Molnar, National Institutes of Health, US
1:30 Nanomedicine: Engineering of a Tri-Imageable Nanoparticle for Cancer Diagnostics
A. Bumb, PJ. Dobson, L. Fugger, P. Choyke, MW. Brechbiel, National Cancer Institute/University of Oxford, US
1:50 Gold Nano-Probes as Targeted CT Contrast Agents for In-vivo cancer Imaging
R. Popovtzer, A. Agrawal, M. Shlomi, A. Popovtzer, J. Balter, T.E. Carey, R. Kopelman, University of Michigan, US
2:10 Electrokinetic Separation and Detection of DNA Nanoparticles and Cancer BioMarkers
M.J. Heller, R. Krishnan, B. Sullivan, R. Mifflin, S. Esener, University of California, San Diego, US
2:30 Development of EGFR-based Glioblastoma Targeting Imaging Agents
U. Trojahn, Z. Zhang, U. Iqbal, M. Jaramillo, J. Baardsnes, A. Abedelnasser, J. Zhang, R. MacKenzie, D. Stanimirovic, T. Veres, B. Tomanek, M. O’Connor-McCourt, McGill University, CA
Back to Top
Biomarkers & NanoparticlesExhibit Hall C
- Reactive Nanoparticles to Mitigate Chemical Contamination for Homeland Security
O.B. Koper, F. Kroh, H. Kwen, S. Rajagopalan, NanoScale Corporation, US
- Optimizing nanoparticle functionalization for quantum dot formation
J.B. Hooper, D. Bedrov, G.D. Smith, H. Kim, University of Utah, US
- Chip-Based Energy Transfer System between Quantum dots and Gold Nanoparticles for Analysis of Protein Glycosylation
Y-P. Kim, S. Park, E. Oh, Y-H. Oh, H-S. Kim, KAIST, KR
- Functionalized Mesoporous Silica Nano-particle for Optical Bio-detection
W.C. Maki, N.N. Mishra, B. Filanoski, S.K. Rastogi, E. Cameron, G. Maki, University of Idaho, US
- Directed Self-Assembly of Bio-Derivatized Nanoparticles into Micron Size Biosensor Devices
M.J. Heller, D. Dehlinger, S. Esener, A. Hsiao, University of California, San Diego, US
- Inhibition of Acetylcholine Esterase Promotes Growth of Silver Nanoparticles: Direct method to Sense Nerve Gases Using Nanotechnology
A. Virel, L.S. Peña, V. Pavlov, CIC Biomagune, ES
- Use of Nanoparticles for Signal Amplification
A. Virel, L.S. Peña, V. Pavlov, CIC Biomagune, ES
- Characterization of magnetotactic bacteria from marine environment of Colombia
S.P. Grisales, V.K. Morillo, M.A. Márquez, A. Morales, U. Lins, Universidad Nacional de Colombia, CO
- Local temperature measurement near remotely heated,ultra-small gold nanoparticles
A. Gupta, H. Denver, D-A Borca-Tasciuc, A. Joshi, R. Kane, M. Hella, Rensselaer Polytechnic Institute, US
- Liposome-Quantum Dot Hybrids as Multimodal Therapeutic & Imaging Agent Delivery Systems
W.T. Al-Jamal, K.T. Al-Jamal, K. Kostarelos, Nanomedicine Laboratory, UK
- Nanoparticles for imaging of transmembrane potential
R.A. Khatchadourian, S.J. Clarke, C. Hollmann, J.L. Nadeau, McGill University, CA
- Gold Nanoparticle Bioconjugates for Biomolecular Imaging and Detection
X. Liu, Q. Dai, J. Coutts, L. Austin, G. Knowles, Q. Huo, University of Central Florida, US
- Human monocyte uptake and carriage of IgG-coated nanoparticles to neuroinflamed brain subregions
A. Béduneau, H. Dou, C. Grotepas, M. Boska, N. Gong, A.V. Kabanov, H.E. Gendelman, University of Nebraska, US
- Dye Coded Nanoparticle as SERRS Labels for Ultrasensitive Detection of Proteins and Antibodies
R. Stevenson, R.J. Stokes, A. Ingram, K. Faulds, D. Graham, The University of Strathclyde, UK
- Functionalized Inorganic Nanostructures for Biomedical Applications
K. Bonroy, H. Jans, B. Van de Broek, K. Jans, G. Reekmans, A. Van Summeren, B. Van Meerbergen, C. Huang, T. Stakenborg, J. Trekker, M. Willems, C. Bartic, K. Verhaegen and G. Borghs, IMEC, BE
- Enrichment of serum phosphopeptide by nanoparticles to identify cancer biomarker
A. Shah, V. Sachdev, A. Bharti, Boston University Medical School, US
 

Tuesday June 3

Back to Top
8:30 Cancer Diagnosis, Imaging and Treatment - 2Room 208
 Session chair: J. Manuel Perez, University of Central Florida, US
8:30 Nanotechnology: A Key Enabler of Personalized Medicine
L. Molnar, National Institutes of Health, US
9:00 Strategies for enhanced brain tumor accumulation of magnetic nanoparticles for potential drug delivery
B. Chertok, A.E. David, V.C. Yang, University of Michigan, US
9:20 5-aminolevulinic Acid Conjugated Gold Nanoparticles for Cancer Treatment
M.K. Khaing Oo, X. Yang, H. Wang, H. Du, Stevens Institute of Technology, US
9:40 Multiwalled Carbon Nanotube-Doxorubicin Supramolecular Complexes for Cancer Therapeutics
H. Ali-Boucetta, K.T. Al-Jamal, K. Kostarelos, The School of Pharmacy, University of London, UK
Back to Top
Drug Delivery & TheraputicsExhibit Hall C
- Utility of Customized Targeted PEG Linkers for the delivery of oligonucleotides without the use of transfection reagents
H. Zhao, P. Reddy, J. Xia, M. Wang, P. Sapra, R. Bandaru, M. Belen Rubio, D. Wu, P. Zhu, D. Filpula, L.M. Greenberger, I.D. Horak, Enzon Pharmaceuticals, Inc., US
- Nanoparticles of the Thermo-mechanically Activated Zeolite in the Design and Synthesis of New Drugs Generation
S. Ivkovic, D. Brezak, MEGAMIN GmbH, DE
- Invention of Polysaccharide-base Nanoparticles for Enhancing Drug Permeability across the Blood Brain Barrier
E.S. Gil, T.L. Lowe, Pennsylvania State University, US
- Molecular Imaging by Nanoparticle Bacterial delivery Systems:
R. Sharma, University of North Carolina, Greensboro, US
- Influence of water-soluble polymers and surfactants, on mebendazole solubilization by _- and permethyl-_-cyclodextrins
O-M. Ba, M. Lahiani-Skiba, S. Joudieh, F. Bounoure, M. Skiba, Université de Rouen, FR
- Synthesis of magnetic nanoparticles and its applications in drug delivery systems
N. Wright Bolden, V. Rangari, S. Jeelani, Tuskegee University, US
- Organisation of peptide ligands on the surface of gene vectors
M. Wang, A.D. Miller, M. Thanou, Imperial College London, UK
- Micellar form of novel poorly soluble pro-apoptotic agent, N-([(2-hydroxy-5-nitrophenyl) amino] carbonothioyl}-3, 5-dimethylbenzamide (PIT) for effective targeting to solid tumors
I. Skidan, A. Degterev, P. Dholakia, V. Torchilin, Northeastern University, US
- TATp-bearing Immunoliposomes for In Vivo Gene Delivery to Ischemic Myocardium
Y.T. Ko, W.C. Hartner, A. Kale, V.P. Torchilin, Northeastern University, US
- Radiolabelled Microspheres As a Delivery System For Targetad Radiotherapy
G.P. Bandopadhyaya, J. Shukla, All India Institute of Medical Sciences, IN
- Lyceum Chinense and Calcium Phosphate Nanoparticles for Ophthalmic Drug Delivery
Q. He, Z. Fang, M. Wang, Q.W. Xu, R. Chen, X.Z. Zhang, W.M. Yaun, D.M. Zhau, Jian Wu, Morehouse School of Medicine, US
- Long-circulating PEGylated PLGA nanoparticles for Drug Delivery
J. Park, P.M. Fong, K.S. Russell, W.M. Saltzman, T.M. Fahmy, Carigent Therapeutics, US
- Encapsulation and Extended release of Anti-cancer Anastrozole by Stealth Nanoparticles
K. Sarkar, H. Yang, Virginia Commonwealth University, US
- How much advantage do Nanoscale Phenomena afford for Pulmonary Delivery?
N. Walji, M. Thanou, N. Quirke, Imperial College London, UK
- Evaluation of the paromomycin loading characteristics in nanoprecipitated PLGA nanospheres
S. Kalimouttou, M. Lahiani-Skiba, N. Naouli, V.S. LIN, M. Skiba, Université de Rouen, FR
- Preparation And Evaluation Of In Vitro Release Of Amphiphilic _-Cyclodextrin Or Pla Nanospheres Containing A Hydrophobic Drug
S. Lin, M. Lahiani-Skiba, N. Naouli, M. Skiba, Université de Rouen, FR
- Step and Flash Imprint Lithography for the Fabrication of Shape-specific, Enzymatically-triggered, Drug Nanocarriers
M. Caldorera-Moore, L.C. Glangchai, L. Shi, K. Roy, The University of Texas at Austin, US
- Layer-By-Layer Formation of Polymer Micro Capsules for Drug Delivery Application
A. Manju, K. Sreenivasan, Sree Chiotra Tirunal Institute for Medical Sciences and Technology, IN
- DNA-Associated Single-walled Carbon Nanotubes as a Platform for Drug Delivery
B.D. Dolash, R.R. Lahiji, D.Y. Zemlyanov, R. Reifenberger, D.E. Bergstrom, Purdue University, US
- Manufacture and in vitro efficacy of lymphoma-targeted doxorubicin-loaded PLGA nanoparticles
J. Lu, M. Nkansah, J. Park, P.M. Fong, Carigent Therapeutics, Inc., US
- High Fidelity Hompolymer Sequencing
S. Goel, P. Griffin, R.W. Davis, M. Ronaghi, Stanford University, US
- Studies of conformational changes induced in a carrier protein: Bovine serum albumin
N. El Kadi, N. Taulier, W. Urbach, M. Waks, Paris V, FR
- Real-time Detection and Quantitation of siRNAs in vivo
A. Cheng, Y. Liang, A. Vlassov, M. Li, Y. Wang, L. Wong, C. Chen, S. Magdaleno, Ambion Inc., An Applied Biosytems Business, US
- Nanoscale Aspects of Pharmaceutical Materials
Y. Yang, P. Schields, L. Brostrom, P. Tishmack, R. McClurg, I. Ivanisevic, S. Bates, J-O. Henck, D. Engers, SSCI, An Aptuit Company, US
Back to Top
Merck Innovation Symposium: siRNA DeliveryExhibit Hall C
- Labile Catalytic Packaging and Delivering of Short Interference RNA to Cancer Cells: Control of Gold Nanoparticles “out” of RNA Complexes
A.M. Chen, O. Taratula, D. Wei, T. Minko, H. He, Rutgers, The State of New Jersey, US
- In vitro transfection efficiency of chitosan nanoparticles for gene delivery
M. Malhotra, A. Kulamarva, S. Sebak, J. Bhathena, S. Prakash, McGill University, CA
- Toward in vivo Targeting Delivery of siRNA for Efficient Cancer Therapy
O. Taratula, P. Kirkpatrick, R. Salva, I. Pandya, T. Minko, H. He, Rutgers-Newark University, US
- SiRNA for Therapeutic Immuno-modulation: Simultaneous Delivery of Cytokine-targeted SiRNA and DNA Antigens to Dendritic Cells using Polymer Microcarriers
A. Singh, H. Nie, B. Ghosn, K. Roy, The University of Texas at Austin, US
- Multilayered ABCD Nanoparticles for siRNA delivery
M. Thanou, A. Miller, Imperial College London, UK
- Delivery systems for enhanced siRNA delivery
A-L. Bolcato-Bellemin, M-E. Bonnet, J-P. Behr, P. Erbacher, Polyplus-transfection, FR
Back to Top
Phage NanobiotechnologyExhibit Hall C
- Phage microarray
K.A. Vaglenov, S.N. Ustinov, G.A. Kuzmicheva, V.A. Petrenko, Auburn University, US
- Modulating affinity of landscape phage nanoparticles by mutagenesis of the major coat protein
G.A. Kuzmicheva, A.M. Eroshkin, V.A. Potemkin, V.A. Petrenko, Auburn University, US
- Landscape phage libraries as a source of bioselective nanomaterials
G.A. Kuzmicheva, I.B. Sorokulova, P.K. Jayanna, V.A. Petrenko, Auburn University, US
- Directed Evolution of Bone Associated Protein Through Phage Display
S.-W. Lee, University of California, Berkeley, US
- Engineering of bacteriophages displaying affinity tags on its head for biosensor applications
M. Tolba, L.Y. Brovko and M.W. Griffiths, University of Guelph, CA
- Engineering hybrid nanostructures with phage particles
L. Makowski, L. Chen, Argonne National Laboratory, US
- Landscape phage probes for PC3 prostate carcinoma cells
P.K. Jayanna, P. Deinnocentes, R.C. Bird, V.A. Petrenko, Auburn University, US
- Landscape Phage Probes for Breast Cancer Cells
O.A. Fagbohun, D. Bedi, P.K. Jayanna, P.A. Deinnocentes, R.C. Bird, V.A. Petrenko, Auburn University, US
- Unspecific uptake of M13-type bacteriophage into human endothelial cell lines.
O.A. Mandrup, P. Kristensen, University of Aarhus, DK
- Phage engineering for neural tissue regeneration
A.M. Merzlyak, S.W. Lee, UC Berkeley, US
- Genetically engineered M13 bacteriophages as standalone tethers for probing single-molecule protein-DNA interactions
A.S. Khalil, J.Y. Mao, D. Ghosh, M.J. Lang, A.M. Belcher, Massachusetts Institute of Technology, US
- High speed Atomic Force Microscopy for imaging Cell-Virus interactions
G.E. Fantner, D.S. Gray, I.W. Rangelow, A.M. Belcher, Massachusetts Institute of Technology, US
- Biotemplated synthesis of materials for photo-oxidation of water
A. Magyar, S. Cui, Y-S Nam, V. Dini, A.M. Belcher, Massachusetts Institute of Technology, US
- Evolutionary selection of bone mineral hydroxyapatite binding peptide using landscape phage library
S. Modali, G. Abbineni, P. Jayanna, V. Petrenko, C. Mao, University of Oklahoma, US
Back to Top
3:30 Merck Innovation Symposium: siRNA DeliveryRoom 208
3:30 Introduction: siRNA Delivery
A. Sachs, Merck, US
3:40 Development of a new RNAi therapeutics platform
J. Kamens, W. Salomon, H. Baigude, J. McCarroll, C.-S. Yang, P. Swain, T. Rana, T. Woolf, D. Samarsky, P. Pavco, RXi Pharmaceutical, US
4:00 Amphoteric liposomes are a platform for multi-organ delivery of oligonucleotides
C. Reinsch, U. Rauchhaus, S. Panzner, novosom AG, DE
4:20 Oral Delivery of Map4K4 siRNA to Macrophages Inhibits TNF alpha Production and Protects against a LPS-Galactosamine Challenge in Mice
M. Aouadi, G. Tesz, E. Soto, M. Wang, S. Nicoloro, G. Ostroff, M. Czech, University of Massachusetts Medical School, US
4:40 Systemic Delivery of Targeted, siRNA-Containing Nanoparticles for the Treatment of Solid Tumors: Concept to Clinic
J.D. Heidel, J.Y-C. Liu, R.K. Zeidan, Y. Liang, S. Rele, M.E. Davis, Calando Pharmaceuticals, US
5:00 Targeting and Delivery of siRNA using Nanoparticles Fabricated via the PRINT Process
D.A. Canelas, X. Gao, S. Tian, P.A. Ropp, J.M. DeSimone, University of North Carolina at Chapel Hill, US
5:20 Long-Circulating Micelle-like DNA-encapsulating Nanoparticles for Systemic Gene Delivery
Y.T. Ko, W.C.A. Kale, V.P. Torchilin, Northeastern University, US
5:40 Efficient siRNA Delivery by Secondary and Tertiary Amine Modified Polysaccharides
B. Ghosn, A. Singh, K. Roy, The University of Texas at Austin, US
 

Wednesday June 4

Back to Top
8:30 Nanotechnology for Cancer Prevention, Diagnosis and TreatmentRoom 210
 Session chair: Vladimir Torchilin, Northeastern University, US
8:30 Cancer Gene Therapy Using Nanoparticle Vectors
J.A. Roth, Anderson Cancer Center, US
9:15 Folate-Targeted Nanoparticle Therapies for Cancer
P.S. Low, Purdue University and Endocyte Pharmaceuticals, US
Back to Top
10:30 Nanotechnology for Cancer Prevention, Diagnosis and TreatmentRoom 210
 Session chair: Vladimir Torchilin, Northeastern University, US
10:30 Clinical Translation of Nanotechnology for Cancer: The NCI Alliance’s Perspective
P. Grodzinski, NCI/NIH, US
11:00 Nanotechnology Applied to Clinical Biomarker Medicine
L. Liotta, George Mason University, US
11:30 Integrated Nanoplatforms for Cancer Detection
S.R. Manalis, Massachusetts Institute of Technology, US
Back to Top
10:30 Phage NanobiotechnologyRoom 209
 Session chair: Valery Petrenko, Auburn University
10:30 Evolution of Phage Display Towards Nanobiotechnology
V. Petrenko, Auburn University, US
10:50 Structure of Filamentous Phage Particles and Their Components
S.J. Opella, University of California, San Diego, US
11:10 Phage Nanoparticles: Replication and Assembly
G.P. Smith, University of Missouri, US
11:30 Phage-Based Patient-Specific Navigation Systems
S.L. Deutscher, University of Missouri, US
11:50 Imaging with Phage Probes
K.A. Kelly, Harvard Medical School/MGH, US
Back to Top
1:30 Nanotechnology for Cancer Prevention, Diagnosis and TreatmentRoom 210
 Session chair: Vladimir Torchilin, Northeastern University, US
1:30 Molecular Imaging in Cancer
A. Moore, MGH/Harvard Medical School, US
2:00 Magnetic Nanoparticles for Thermal Therapy
J. Hoopes, Dartmouth Medical Center, Hanover, NH, US
2:30 Nanocarriers for Tumor-Targeted Drug Delivery
T. Minko, Rutgers, US
Back to Top
1:30 Phage NanobiotechnologyRoom 209
 Session chair: Angela M. Belcher, Massachusetts Institute of Technology, US
1:30 Phage-derived Vehicles for Gene and Drug Delivery
V. Petrenko, Auburn University, US
1:50 Phage-Templated Synthesis of Inorganic Nanomaterials
A.M. Belcher, Massachusetts Institute of Technology, US
2:10 Site-Directed Chemical Modification of Phage Particles
C.J. Noren, New England Biolabs, US
2:30 Phage-based Biorecognition Interfaces in Biosensors
B.A. Chin, Auburn University, US
2:50 Human tumor-specific phage nanoparticles
D. Krag, The University of Vermont, US
Back to Top
3:30 Nanotechnology for Cancer Prevention, Diagnosis and TreatmentRoom 210
 Session chair: Vladimir Torchilin, Northeastern University, US
3:30 Nanocell Delivery System for Combination Cancer Therapy
M.N. Milton, Tempo Pharmaceuticals, US
4:00 Multifunctional Nanocarriers for Cancer Therapy
V. Torchilin, Northeastern University, US
Back to Top
4:00 Phage NanobiotechnologyRoom 209
 Session chair: Valery Petrenko, Auburn University
4:00 Combinatorial Phage Nanobiotechnology
L. Makowski, Argonne National Laboratory, US
4:20 Targeting Nanoparticle Probes to Differentiating Stem Cells
J. Cabral-Teixeira, K. Benjamin, L. Zhang, J. Maurer, M. Tsuda, Y.S. Chao, N. Prigozhina, J. Price, E. Snyder, M. Mercola, E. Ruoslahti, M.D. West, D. Larocca, Advanced Cell Technology, US
4:40 Phage Probes for Cancer Diagnostic and Treatment
T.I. Samoylova, N.E. Morrison, N.R. Cox, Auburn University, US
5:00 Pharmacokinetic Optimization of Phage Particles for Gene-Delivery
A. Baird, D. Larocca, University of California San Diego Medical Center, US
5:20 Targeted Drug-carrying Filamentous Phage Nanomedicines
I. Yacoby, H. Bar, L. Vax, I. Benhar, Tel Aviv University, IL
Back to Top
Cancer Diagnostics, Imaging & TreatmentRoom 302
- Genomics and Proteomics: Information-Theoretic Analysis in Frequency Domain
S.E. Lyshevski, F. Krueger, Rochester Institute of Technology, US
- Colorectal Cancer Cell Detection by Chitosan Nanoparticle Conjugated with Folic Acid
S-J Yang, J-W Chen, M-J Shieh, Institute of Biomedical Engineering, TW
- Chitosan Nanoparticle Combined with Ultrasound for Cervical Cancer Detection
K-C Tsai, M-J Shieh, S-J Yang, W-L Lin, W-S Chen, Institute of Biomedical Engineering, TW
- Lipid core near infrared imaging agent for in vivo whole body imaging
A. Papagiannaros, A. Kale, D. Chovatia, T. Levchenko, W. Hartner, D. Mongayt, V. Torchilin, Northeastern University, US
- Cancer Cell Diagnosis by Targeted Delivery of Nanodevices
I. Hajdu, E. Nagy, M. Bodnar, J.F. Hartmann, S. Damjanovich, J. Kollar, G. Vamosi, J. Borbely, University of Debrecen, HU
- Functionalized quantum dot-liposome hybrid nanoparticles for cancer
W.T. Al-Jamal, K.T. Al-Jamal, K. Kostarelos, Nanomedicine Laboratory, UK
- Developing superparamagnetic iron oxide nanoparticles as tumor-specific magnetic resonance imaging (MRI) contrast agents
R.M. Sawant, E. Gultepe, D. Nagesha, S. Sridhar, V.P. Torchilin, Northeastern University, US
- Biochip-Based Test System for Cancer Diagnostics. Simultaneous Quantitation of Total and Free Forms of Prostate-Specific Antigen
T. Osipova, Z. Sokolova, T. Ryabykh, V. Karaseva, M. Modorsky, V. Matveev, A. Baryshnikov, N.N. Blokhin Cancer Research Center, RAMS, RU
- Novel Micellular Formulations of a Polyethylene Glycolated Pyropheophorbide-a-Peptide Conjugate for Photodiagnosis and Photodynamic Therapy
M.D. Savellano, Dartmouth College, US
- Newer Nanoparticles in Hyperthermia Treatment and Thermometry
R. Sharma, C.J. Chen, Florida State University, US
- Specific device for cells sampling
M.L. Cosnier, F. Martin, D. Ratel, F. Berger, P. Caillat, Commissariat à l’énergie atomique, FR
- New efficient nanostructural near-IR photosensitizer for photodynamic therapy of malignancies based on micellar dispersion of zinc octa-4,5-decylthio-3,6-chloro-phthalocyanine
I.G. Meerovich, G.A. Meerovich, E.A. Lukyanets, V.M. Negrimovsky, S.V. Barkanova, A.A. Zorin, L.V. Umnova, N.A. Oborotova, V.B. Loschenov, G.N. Vorozhtsov, A.Yu. Baryshnikov, N.N.Blokhin Russian Cancer Research Center of RAMS, RU
- Influence of liposome size on accumulation in tumor and therapeutic efficiency of liposomal near-IR photosensitizer for PDT based on aluminum hydroxide tetra-3-phenylthiophthalocyanine
G.A. Meerovich, I.G. Meerovich, V.G. Pevgov, E.A. Lukyanets, N.A. Oborotova, D.G. Gurevich, A.A. Zorin, V.M. Derkacheva, Z.S. Smirnova, V.B. Loschenov, G.N. Vorozhtsov, A.Yu. Baryshnikov, A.M. Prokhorov General Physics Institute of RAS, RU
- Mathematical Model of effect of drug delivery on blood flow in external magnetic field by Magnetic Nanoparticles
S. Mishra, V.K. Katiyar, V. Arora, Indian Institute of Technology Roorkee, IN
- Fabrication of magnetic Co-Ferrite-SiO2 nanoparticles using Hydroxyapatite (HAp) as templates for nanomedicine
W. Pon-on, Mahidol University, TH
- Multifunctional siRNA Delivery System for Cancer Therapy
O. Taratula, R. Salva, I. Pandya, A. Wang, T. Minko, H. He, Rutgers-Newark University, US
- Preparation and investigation of biological activity of thermosensitive liposomes loaded with doxorubicin
E.V. Tazina, A.V. Polozkova, O.L. Orlova, E.V. Ignatieva, V.V. Mescherikova, A. Wainson, S.P. Yarmonenko, N.A. Oborotova, N.N. Blokhin Russian Cancer Research Center of RAMS, RU
- Multi- Walled Carbon Nanotubes Increase the Efficiency of Hyperthermic Chemotherapy
N.H. Levi-Polyachenko, E. Merkel, B.T. Jones, W.D. Wagner, D.L. Carroll, J.H. Stewart IV, Wake Forest University Health Sciences, US
- Bacterial Drug Delivery Systems and nanoparticles
R. Sharma, Y. Haik, UNCG, US
- Immunomicelles for Delivery of Poorly Soluble Anticancer Drugs: Improved Solubilization and In Vitro Cytotoxicity
R.R. Sawant, V.P. Torchilin, Northeastern University, US
- Structural plasticity of transmembrane peptides allows generation of self-assembling uniform nanoparticles with innate biological activity
S.G. Tarasov, V. Gaponenko, O.M.Z. Howard, M. Dyba, S. Subramaniam, C.J. Michejda, N.I. Tarasova, National Cancer Institute at Frederick, US
- Pharmacokinetic study of PEGylated plasmon resonant gold nanoparticles in tumor-bearing mice
B.Ya. Kogan, N.V. Andronova, N.G. Khlebtsov, B.N. Khlebtsov, V.M. Rudoy, O.V. Dement’eva, E.M. Sedykh, L.N. Bannykh, FGUP “GNC “NIOPIK”, RU
- Upconverting nanoparticles for photodynamic therapy
D.K. Chatterjee, Y. Zhang, National University of Singapore, SG
- Spatio-temporal Tumor Model for Analysis and Mechanism of action of Intracellular Drug Accumulation
S. Mishra, V.K. Katiyar, V. Arora, Haridwar, IN
 

Thursday June 5

Back to Top
8:30 Biomarkers and NanoparticlesRoom 308
 Session chair: Srinivas Iyer, LANL, US
8:30 Multiplexed Proteolytic Enzyme Assay Based on Energy Transfer between Quantum Dots and Gold Nanoparticles
Y.H. Oh, Y.P. Kim, H.S. Kim, Korea Abvanced Institute of science and Technology, KR
8:50 2-Nitroimidazole as Potential Nanoprobe in Hypoxia Imaging by MRI/PET
R. Sharma, A. Sharma, University of North Carolina, US
9:10 Biomolecular activity switch: an application of metallic nanoparticle plasmon resonance
J. Alper, A. Wijaya, M. Crespo, L. DeFlores, A. Tokmakoff, K. Hamad-Schifferli, Massachusetts Institute of Technology, US
9:30 Functional Nanoparticles for Biomedical Applications
Y. Durant, E. de Muinck, Nanostructured Polymers Research Center, US
9:50 Multifunctional nanoparticle platforms for pathogen diagnostic applications
A.J. Kell, C. Paquet, B. Simard, National Research Council, CA
Back to Top
10:30 Drug and Gene Delivery SystemsRoom 311
 Session chair: Steve Xanthoudakis, Merck, US
10:30 Cell-mediated, heat-based therapy for combating HIV infection
H.T. Denver, C.M. de Noronha, D.-A. Borca-Tasciuc, Rensselaer Polytechnic Institute, US
10:50 A broad-spectrum viricide and its application as a novel human anti-viral therapeutic system
E. Seymour, A. Diwan, V. Boniuk, R. Barton, NanoViricides, Inc., US
11:10 Gene Delivery and Transfection Studies with Lipopolyplexes in Human Endothelial and Smooth Muscle Cells
L. Brito, S. Little, R. Langer, M. Amiji, Northeastern University, US
11:30 A Micro-Implant based on MEMS (Micro-Electro-Mechanical-Sysems) Technology for Treatment of Hemorrhagic Shock in Ambulatory Settings
N.M. Elman, H-L. Ho Duc, M.J. Cima, Massachusttes Institute of Technology, US
11:50 Development of Peptide Nucleic Acid Assemblies for Application in Drug Delivery and Molecular Sensing
F.N. Butler, O. Elibol, B.D. Hines, B. Reddy Jr., R. Bashir, D.E. Bergstrom, Purdue University, US
 

Special Symposium

This session seeks to showcase work in the area of biomedical nanotechnology, particularly related to drug delivery.

Nanoscience and nanotechnology can address one of the greatest challenges in the post-genomic era of the 21st century — making the essential connections between structure and function of biomolecules at the micro/nanoscale to human physiology and pathophysiology at the macroscale.

To meet these challenges, the field of biomedical nanotechnology has undergone exponential growth during the last 5 years. Technologies such as nanostructured biomaterials for biointegration, nanoprobes for cellular targeting, and nanofluidic chips for DNA processing and drug delivery promise to transform the world of biochemistry and medicine much in the same way that integrated semiconductor devices transformed the world of electronics and computation.

The key driving force is the complementary length scale between biological structures that range from the 10's of nanometers (proteins, DNA, viruses) to the micron scale (cells and cellular assemblies) and the new capabilities of nanosystems to manipulate and control such feature sizes within our environment.

Topics & Application Areas

Online abstract submissions are now being accepted. Proposed topics include, but are not be limited to:

  • Targeting at Molecular, Cellular & Higher Levels
  • Delivery Systems
  • Modes of Entry
  • Controlled Release Systems
  • Microcapsules
  • Liposomes
  • Macromolecular Conjugates
  • Antibody Targeting
  • Protein/Peptide Delivery
  • Pharmacodynamics
  • Other

Journal Submissions

Nanomedicine: Nanotechnology, Biology and Medicine (Nanomedicine)

Nanomedicine: Nanotechnology, Biology and Medicine (Nanomedicine)

Nanomedicine: Nanotechnology, Biology and Medicine (Nanomedicine) is a newly established, international, peer-reviewed journal published quarterly. Nanomedicine publishes basic, clinical, and engineering research in the innovative field of nanomedicine. Article categories include basic nanomedicine, diagnostic nanomedicine, experimental nanomedicine, clinical nanomedicine, and engineering nanomedicine, pharmacological nanomedicine.

For consideration into the Nanomedicine: Nanotechnology, Biology and Medicine journal please select the “Submit to Nanomedicine: Nanotechnology, Biology and Medicine” button during the on-line submission procedure. You may only select a single journal during the submission process.

Journal of Nanoparticle Research

Journal of Nanoparticle Research

Selected Nanotech Proceedings papers will be reviewed and invited into a Special Issue of Journal of Nanoparticle Research. The journal disseminates knowledge of the physical, chemical and biological phenomena and processes in nanoscale structures.

For consideration into this Special Issue of Journal of Nanoparticle Research, please select the “Submit to Journal of Nanoparticle Research” button during the on-line submission procedure. You may only select a single journal during the submission process.


Symposium Coordinator

Matthew Laudon
Nano Science and Technology Institute